Exploring rapid relief with amylmetacresol/2,4-dichlorobenzyl alcohol lozenges and the broad antiseptic activity of hexetidine gargle
An itchy or scratchy throat may be the first clue that you are developing pharyngitis, more commonly known as sore throat.1,2 It may seem minor at first, but increasing discomfort can affect swallowing, speaking, sleep, concentration, and work.1,3 Timely symptom management may help you remain comfortable and help you go about your everyday activities with less trouble.
In a 13-country survey including the Philippines, the most commonly cited reason for seeking treatment for sore throat was preventing symptoms from getting worse. 90% of the respondents said they look to pharmacists and general practitioners for this medical advice.1 This data places healthcare practitioners in an important position to guide timely and evidence-based therapeutic options.
[Sore throat] may seem minor at first, but increasing discomfort can affect swallowing, speaking, sleep, concentration, and work.1,3
Rapid relief through anesthetic action
Non-medicated lozenges are a common option for soothing throat discomfort. However, when sore throat progresses and discomfort spikes, prompt relief makes a meaningful difference. Over the counter medicated lozenges like Bactidol Extra Soothing Lozenges, containing amylmetacresol/2,4-dichlorobenzyl alcohol provide rapid relief by acting like local anesthetics for the throat coupled with their antiseptic property.4,5
In a randomized trial of 310 adults, amylmetacresol/2,4-dichlorobenzyl alcohol throat lozenges showed improvement in throat soreness from 5 minutes after the first dose and relief lasting for up to 2 hours. With continued use over 3 days, patients also reported that these lozenges made swallowing easier and helped them keep up more easily with their day-to-day activities.6 These findings support amylmetacresol/2,4-dichlorobenzyl alcohol lozenges as an evidence-based option for promptly addressing both throat discomfort and its impact on everyday function.
Early care beyond a soothing rinse
Aside from prompt relief, addressing the underlying cause of sore throat plays an important role. About 90% of throat infections are viral.2 In otherwise healthy individuals, uncomplicated viral pharyngitis generally resolves without long-term complications, but patients can still experience significant discomfort while they are affected. This warrants prompt management while also helping patients recognize symptoms that may require further evaluation.1,7
Many patients gargle salt water to help manage their symptoms. While this can provide some relief, it has not been conclusively shown to reduce respiratory viral load. Medicated gargles offer a different approach. Hexetidine, the medicated content of Bactidol gargle, provides a broad-spectrum antiseptic action and has been shown to kill several sore-throat causing respiratory viruses in laboratory studies.8-10
A published topical therapy algorithm positions hexetidine as an option for early, mild tonsillopharyngitis of mixed etiology, before marked inflammation develops.11 Hexetidine has also been evaluated in a published pilot randomized controlled trial involving patients with SARS-CoV-2 infection.12 These findings are summarized below.
Table 1: Evidence on the anti-viral activity of hexetidine gargle
Evidence evaluated | Salt-water gargle | Hexetidine gargle |
|---|---|---|
SARS-CoV-2, in vitro⁷ | No significant reduction in viral titer after 30-second exposure | >5-log₁₀ reduction in viral titer after 30-second exposure |
Selected non-COVID viruses, in vitro⁸ | Not evaluated in the cited studies | ≥100-fold reduction in infectivity of influenza A/H5N1, pandemic influenza A/H1N1, respiratory syncytial virus, and herpes simplex virus type 1 after 30-second exposure |
Seasonal coronavirus and influenza, in vitro⁹ | Not evaluated | >80% reduction in infectivity of human coronavirus OC43 and influenza A/H1N1 at concentrations of 25%, 50%, and 100% after 15- and 30-second exposures |
SARS-CoV-2 pilot RCT¹¹ | Not evaluated | 69.2% converted to negative sputum RT-PCR at 15 minutes* vs demineralized sterile water, with 46.7% converting to negative sputum RT-PCR at 15 minutes* *Differences between groups were not statistically significant across assessed time points. |
Note: Laboratory antiviral activity and short-term RT-PCR conversion do not establish viral eradication, symptom improvement, faster recovery, or prevention of complications in patients with viral pharyngitis.
At the first signs of throat discomfort, Hexetidine (Bactidol gargle) offers broad antiseptic activity supported by laboratory antiviral evidence, while amylmetacresol/2,4-dichlorobenzyl alcohol (Bactidol Extra Soothing Lozenges) provide a complementary locally acting option for rapid symptom relief. Together, they support a timely, evidence-based approach to uncomplicated sore throat.
Note: Persistent or worsening symptoms warrant evaluation by a licensed physician.
REFERENCES
van der Velden AW, Sessa A, Altiner A, et al. Pragmat Obs Res 2020;11:91-102.
Harvard Health Publishing. Sore throat (pharyngitis A to Z). Accessed August 19, 2026. https://www.health.harvard.edu/ear-nose-and-throat/sore-throat-pharyngitis-a-to-z
Addey D, Shephard A. BMC Ear Nose Throat Disord 2012;12:9.
Weckmann G, Hauptmann-Voß A. Int J Clin Pract 2017;71(10):10.1111/ijcp.13002.
Bactidol Extra Soothing Lozenges. Bactidol. Available at https://www.bactidol.com.ph/products/lozenge. Accessed September 2026.
McNally D, Simpson M, Morris C, et al. Int J Clin Pract 2010;64(2):194-207.
Goldin J, Graber M. Acute pharyngitis. In: StatPearls. StatPearls Publishing; 2026. Updated October 6, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559007/. Accessed August 2026.
Tiong V, Hassandarvish P, Bakar SA, et al. Sci Rep 2021;11(1):20502.
Deryabin PG, et al. Bull Exp Biol Med 2016;160(3):353-356.
Tobias-Altura MC, Ngelangel CA. Philipp J Health Res Dev 2022;26(suppl 1):1-6.
Ryazantsev SV, Artyushkin SA, Eremin SA, et al. Russian Otorhinolaryngology 2023;22(4):133-139.
Ogun SA, Erinoso O, Aina OO, et al. West Afr J Med 2022;39(1):83-89.